These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15754993)

  • 21. Can human papillomavirus DNA testing substitute for cytology in the detection of high-grade cervical lesions?
    Lee KJ; Lee JK; Saw HS
    Arch Pathol Lab Med; 2004 Mar; 128(3):298-302. PubMed ID: 14987159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
    Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
    Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competing-risks regression models in analysis of biomarkers as predictors of high-risk human papillomavirus (HPV) infection outcomes and incident CIN in the LAMS cohort.
    Syrjänen S; Longhato-Filho A; Sarian LO; Naud P; Derchain S; Rottelli-Martins C; Tatti S; Branca M; Eržen M; Hammes LS; Matos J; Gontijo R; Bragança J; Arlindo FC; Maeda MY; Costa S; Syrjänen K
    Int J Gynecol Pathol; 2013 Jul; 32(4):406-15. PubMed ID: 23722514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia.
    Resnick M; Lester S; Tate JE; Sheets EE; Sparks C; Crum CP
    Hum Pathol; 1996 Mar; 27(3):234-9. PubMed ID: 8600036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions.
    Bello BD; Spinillo A; Alberizzi P; Cesari S; Gardella B; D'Ambrosio G; Roccio M; Silini EM
    J Med Virol; 2009 Apr; 81(4):703-12. PubMed ID: 19235847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasia.
    Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Longatto-Filho A; Syrjänen K
    Am J Clin Pathol; 2010 Jul; 134(1):50-9. PubMed ID: 20551266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica.
    Wang SS; Trunk M; Schiffman M; Herrero R; Sherman ME; Burk RD; Hildesheim A; Bratti MC; Wright T; Rodriguez AC; Chen S; Reichert A; von Knebel Doeberitz C; Ridder R; von Knebel Doeberitz M
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1355-60. PubMed ID: 15298958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
    Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
    [No Abstract]   [Full Text] [Related]  

  • 29. High risk HPV in situ hybridization, p16 INK 4A, and survivin expressions in cervical carcinomas and intraepithelial neoplasms: evaluation of prognostic factors.
    Demir F; Kimiloglu E; Igdem AA; Ayanoglu YT; Erdogan N
    Eur J Gynaecol Oncol; 2014; 35(6):708-17. PubMed ID: 25556279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray.
    Hwang TS; Jeong JK; Park M; Han HS; Choi HK; Park TS
    Gynecol Oncol; 2003 Jul; 90(1):51-6. PubMed ID: 12821341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women.
    Roteli-Martins CM; Panetta K; Alves VA; Siqueira SA; Syrjänen KJ; Derchain SF
    Acta Obstet Gynecol Scand; 1998 Jul; 77(6):678-82. PubMed ID: 9688248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables.
    Kruse AJ; Baak JP; Janssen EA; Bol MG; Kjellevold KH; Fianne B; Lovslett K; Bergh J
    J Pathol; 2003 Apr; 199(4):462-70. PubMed ID: 12635137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle regulators p105, p107, Rb2/p130, E2F4, p21CIP1/WAF1, cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union.
    Santopietro R; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Cintorino M; Tosi P; Syrjänen K; Syrjänen S
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1250-6. PubMed ID: 16835319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.
    Sand FL; Munk C; Frederiksen K; Junge J; Iftner T; Dehlendorff C; Kjaer SK
    Int J Cancer; 2019 Apr; 144(8):1975-1982. PubMed ID: 30246864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
    J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Human papilloma virus and cervical cancer].
    Kawana T
    Gan To Kagaku Ryoho; 1995 May; 22(6):711-7. PubMed ID: 7755378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study on cervical intraepithelial neoplasia with high-risk HPV infection among pregnant women].
    He Y; Wu YM; Wang T; Song F; Wang Y; Zhao Q; Kong WM; Duan W; Zhu L; Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):598-602. PubMed ID: 23141180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
    J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DEK overexpression in uterine cervical cancers.
    Wu Q; Li Z; Lin H; Han L; Liu S; Lin Z
    Pathol Int; 2008 Jun; 58(6):378-82. PubMed ID: 18477217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.